Aequus Pharmaceuticals Inc. filed its Annual on May 01, 2023 for the period ending Dec 31, 2022. In this report its auditor, Smythe LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | +20.00% | +100.00% | +20.00% |
1st Jan change | Capi. | |
---|---|---|
+20.00% | 2.43M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- AQS Stock
- News Aequus Pharmaceuticals Inc.
- Aequus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt